02.25.13
A Mediterranean diet supplemented with extra-virgin olive oil or nuts may reduce the risk of major cardiovascular events among at risk populations, according to research published in the New England Journal of Medicine.
Previous research has shown an inverse association between adherence to the Mediterranean diet and cardiovascular risk, study authors noted. For this trial, researchers conducted a randomized trial of this diet pattern for the primary prevention of cardiovascular events.
In a multicenter trial in Spain, researchers randomly assigned participants who were at high cardiovascular risk, but with no cardiovascular disease at enrollment, to one of three diets: a Mediterranean diet supplemented with extra-virgin olive oil, a Mediterranean diet supplemented with mixed nuts or a control diet (advice to reduce dietary fat).
Participants received quarterly individual and group educational sessions and, depending on group assignment, free provision of extra-virgin olive oil, mixed nuts or small nonfood gifts. The primary end point was the rate of major cardiovascular events (myocardial infarction, stroke or death from cardiovascular causes). On the basis of the results of an interim analysis, the trial was stopped after a median follow-up of 4.8 years.
A total of 7,447 persons were enrolled (age range, 55 to 80 years); 57% were women. The two Mediterranean-diet groups had good adherence to the intervention, according to self-reported intake and biomarker analyses. A primary end-point event occurred in 288 participants. The multivariable-adjusted hazard ratios were 0.70 (95% confidence interval [CI], 0.54 to 0.92) and 0.72 (95% CI, 0.54 to 0.96) for the group assigned to a Mediterranean diet with extra-virgin olive oil (96 events) and the group assigned to a Mediterranean diet with nuts (83 events), respectively, versus the control group (109 events). No diet-related adverse effects were reported.
Previous research has shown an inverse association between adherence to the Mediterranean diet and cardiovascular risk, study authors noted. For this trial, researchers conducted a randomized trial of this diet pattern for the primary prevention of cardiovascular events.
In a multicenter trial in Spain, researchers randomly assigned participants who were at high cardiovascular risk, but with no cardiovascular disease at enrollment, to one of three diets: a Mediterranean diet supplemented with extra-virgin olive oil, a Mediterranean diet supplemented with mixed nuts or a control diet (advice to reduce dietary fat).
Participants received quarterly individual and group educational sessions and, depending on group assignment, free provision of extra-virgin olive oil, mixed nuts or small nonfood gifts. The primary end point was the rate of major cardiovascular events (myocardial infarction, stroke or death from cardiovascular causes). On the basis of the results of an interim analysis, the trial was stopped after a median follow-up of 4.8 years.
A total of 7,447 persons were enrolled (age range, 55 to 80 years); 57% were women. The two Mediterranean-diet groups had good adherence to the intervention, according to self-reported intake and biomarker analyses. A primary end-point event occurred in 288 participants. The multivariable-adjusted hazard ratios were 0.70 (95% confidence interval [CI], 0.54 to 0.92) and 0.72 (95% CI, 0.54 to 0.96) for the group assigned to a Mediterranean diet with extra-virgin olive oil (96 events) and the group assigned to a Mediterranean diet with nuts (83 events), respectively, versus the control group (109 events). No diet-related adverse effects were reported.
